Argent Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Argent Trust CO

$2.39 Billion
Q3 2024

A detailed history of Argent Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Argent Trust CO holds 2,389 shares of REGN stock, worth $1.68 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,389

Previous 2,370 0.8%

Holding current value

$1.68 Million

Previous $2.49 Million 0.84%

% of portfolio

0.11%

Previous 0.11%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $19,457 - $22,833	19 Added 0.8%	2,389 $2.51 Million
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $27,379 - $33,206	31 Added 1.33%	2,370 $2.49 Million
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $158,873 - $174,829	176 Added 8.14%	2,339 $2.25 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $74,417 - $84,643	96 Added 4.64%	2,163 $1.9 Million
Q3 2023 Nov 08, 2023	BUY	$692.45 - $844.37 $63,012 - $76,837	91 Added 4.61%	2,067 $1.7 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $319,913 - $379,469	457 Added 30.09%	1,976 $1.42 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $7,485 - $9,096	-11 Reduced 0.72%	1,519 $1.25 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $27,529 - $29,889	-39 Reduced 2.49%	1,530 $1.1 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $20,088 - $25,351	35 Added 2.28%	1,569 $1.08 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $11,515 - $15,515	21 Added 1.39%	1,534 $907,000
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $8,331 - $9,778	-14 Reduced 0.92%	1,513 $1.06 Million
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $637,502 - $787,047	1,173 Added 331.36%	1,527 $964,000
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $203,206 - $241,059	354 New	354 $214,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account